NCT05551117 2026-02-09
Tamarack
MacroGenics
Phase 2 Terminated
MacroGenics
University of California, San Francisco
EpicentRx, Inc.
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
Tufts Medical Center
Clinica Universidad de Navarra, Universidad de Navarra
Eli Lilly and Company